 |
인쇄하기
취소
|
Newgenpharm to acquire license for cancer gene therapy.
Newgenpharm announced to acquire "Celagen" an anti-cancer gene therapy from Henry Ford hospital in the United States, which was scheduled to commercialize until 2008.
Dr. Kim Jae-ho and colleagues of Henry Ford hospital made a technology transfer to Newgenpharm at Sogongdong Lotte hotel, Seoul for the exclusive distribution of Celagen, an anti-cancer gene therapy in 7 countries including Kor...
Dr. Kim Jae-ho and colleagues of Henry Ford hospital made a technology transfer to Newgenpharm at Sogongdong Lotte hotel, Seoul for the exclusive distribution of Celagen, an anti-cancer gene therapy in 7 countries including Kor...
Fees
- Email service daily and homepage access.
- $300 per month.
- 5 Email holders per each company.
- Anual contract base.
Copyright Yakup.com All rights reserved.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.
약업닷컴의 모든 컨텐츠는 저작권법의 보호를 받습니다. 무단 전재⋅복사⋅배포 등을 금합니다.